Prophylactic treatment with nilotinib for post-allogeneic stem cell transplantation cytomegalovirus infection: interim analysis of a phase II trial

被引：0
|
作者：
Wu, S. J. [1 ]
Lin, C. T. [1 ]
Lin, W. P. [1 ]
Li, C. C. [1 ]
Ko, B. S. [1 ]
Yao, M. [1 ]
Tang, J. L. [1 ]
Tien, H. F. [1 ]
机构：
[1] Natl Taiwan Univ Hosp, Taipei, Taiwan
来源：
BONE MARROW TRANSPLANTATION | 2012年 / 47卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S139 / S139
页数：1
相关论文
共 50 条
  • [1] PROPHYLAXIS OF CMV INFECTION AFTER ALLOGENEIC STEM CELL TRANSPLANTATION WITH NILOTINIB : A PHASE II TRIAL
    Lin, C. T.
    Wu, S. J.
    Li, C. C.
    Ko, B. S.
    Yao, M.
    Lin, W. P.
    Tang, J. L.
    Tien, H. F.
    [J]. HAEMATOLOGICA, 2014, 99 : 423 - 423
  • [2] Repurposing Nilotinib for Cytomegalovirus Infection Prophylaxis after Allogeneic Hematopoietic Stem Cell Transplantation: A Single-Arm, Phase II Trial
    Lin, Chien-Ting
    Hsueh, Po-Ren
    Wu, Shang-Ju
    Yao, Ming
    Ko, Bor-Sheng
    Li, Chi-Cheng
    Hsu, Cheng-An
    Tang, Jih-Luh
    Tien, Hwei-Fang
    [J]. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2018, 24 (11) : 2310 - 2315
  • [3] Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: Experience from a Country with High Seropositivity
    Iftikhar, Raheel
    Farhan, Muhammad
    Khan, Maryam
    Chaudhry, Qamar Un Nisa
    Ghafoor, Tariq
    Shahbaz, Nighat
    Khan, Mehreen Ali
    Khattak, Tariq Azam
    Rehman, Jahanzeb
    Humayun, Saima
    Majeed, Aneela
    [J]. TRANSPLANTATION AND CELLULAR THERAPY, 2023, 29 (08): : 521.e1 - 521.e7
  • [4] Acute Disseminated Encephalomyelitis in Post-Allogeneic Peripheral Blood Stem Cell Transplantation with Subclinical Cytomegalovirus Infection
    Ng, C. F.
    Asyraf, W. Z. Wan
    Khoo, C. S.
    Rabani, R.
    Nafisah, W. Y.
    Tan, H. J.
    Norlinah, M. I.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2018, 24 (03) : 420 - 421
  • [5] At-Home Foscarnet Administration in Patients with Cytomegalovirus Infection Post-Allogeneic Stem Cell Transplantation: A Unicentric, Safe, and Feasible Program
    Ruiz-Boy, Sonia
    Pedraza, Alexandra
    Prat, Marta
    Salas, Maria Queralt
    Carcelero, Esther
    Riu-Viladoms, Gisela
    Suarez-Lledo, Maria
    Monge-Escartin, Ines
    Rodriguez-Lobato, Luis Gerardo
    Martinez-Roca, Alexandra
    Rovira, Montserrat
    Martinez, Carmen
    Gallego, Cristina
    Urbano-Ispizua, Alvaro
    Sanchez, Joan
    Marcos, Maria Angeles
    Fernandez-Aviles, Francesc
    [J]. PHARMACEUTICALS, 2023, 16 (12)
  • [6] Treatment of post-allogeneic stem cell transplant cytopenias with sequential doses of mesenchymal stromal cells: results of a multicenter Phase II trial
    Veiga, A.
    Redondo, A.
    Villaron, E.
    Lopez-Parra, M.
    Arratibel, N.
    Baile, M.
    Lopez-Villar, O.
    Cabrero, M.
    Perez, E.
    Lopez-Corral, L.
    Vazquez, L.
    Perez-Simon, J. A.
    Prosper, F.
    Caballero, M. D.
    Canizo, M. C. D.
    Sanchez-Guijo, F.
    [J]. BONE MARROW TRANSPLANTATION, 2017, 52 : S58 - S59
  • [7] Support group for parents of children post-allogeneic stem cell transplantation
    Hutt, D
    Weiss, M
    [J]. BONE MARROW TRANSPLANTATION, 2004, 33 : S262 - S263
  • [8] A case of post-allogeneic haematopoietic stem cell transplantation membranous nephropathy
    Sugimoto, Toshiro
    Tanaka, Yuki
    Sakaguchi, Masayoshi
    Osawa, Norihisa
    Tanaka, Yuki
    Uzu, Takashi
    Kashiwagi, Atsunori
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 (11) : 3362 - 3363
  • [9] HHV7 post-allogeneic hematopoietic stem cell transplantation
    Gassas, Adam
    Doyle, John
    Tellier, Raymond
    [J]. PEDIATRIC BLOOD & CANCER, 2008, 50 (04) : 936 - 936
  • [10] Vaccination post-allogeneic hematopoietic stem cell transplantation: what is feasible?
    Conrad, Anne
    Alcazer, Vincent
    Valour, Florent
    Ader, Florence
    [J]. EXPERT REVIEW OF VACCINES, 2018, 17 (04) : 299 - 309
12345